Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. the Hoorn Study

Diabetologia

Volumn 56, Issue 5, 2013, Pages 1148-1154

  Walraven, I ^a,b   Van 'T Riet, E ^a,b   Stehouwer, C D A ^c   Polak, B C P ^a,b   Moll, A C ^a,b   Dekker, J M ^a,b   Nijpels, G ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cancer; Cancer mortality; Epidemiology; Glucose metabolism; Proinsulin; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN; PROINSULIN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER MORTALITY; COHORT ANALYSIS; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SMOKING; SURVIVAL RATE;

AGED; BIOLOGICAL MARKERS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; MALE; MEDICAL RECORDS; MIDDLE AGED; MORTALITY; NEOPLASMS; NETHERLANDS; PROINSULIN; REGISTRIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84876495093     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2864-6     Document Type: Article

References (24)

1. Yang XL, Ma RCW, Chan JCN (2011) Meta-analysis of trial data may support a causal role of hyperglycaemia in cancer. Diabetologia 54:709-710
2. Yang X, Ko GTC, So WY, et al.(2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: The Hong Kong Diabetes Registry. Diabetes 59:1254-1260
3. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160-1167
4. Rapp K, Schroeder J, Klenk J, et al.(2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49:945-952
5. Harding JL, Soderberg S, Shaw JE, et al.(2012) All-cause cancer mortality over 15 years in multi-ethnic Mauritius: the impact of diabetes and intermediate forms of glucose tolerance. Int J Cancer 131:2385-2393
6. Saydah SH, Loria CM, Eberhardt MS, Brancati FL (2003) Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 157:1092-1100
7. Zhou X, Qiao Q, Zethelius B, et al.(2010) Diabetes, prediabetes and cancer mortality. Diabetologia 53:1867-1876
8. Pollak M (2008) Insulin, insulin-like growth factors and neoplasia. Best Practice & Research Clinical Endocrinology & Metabolism 22:625-638
9. Larsson H, Ahrén B (1999) Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance. J Clin Endocrinol Metab 84:2068-2074
10. Mykkänen L, Haffner S, Kuusisto J, Pyörälä K, Hales C, Laakso M (1995) Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 38:1176-1182
11. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ (1996) Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study. Diabetologia 39:113-118
12. Pfützner A, Kunt T, Hohberg C, et al.(2004) Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes. Diabetes Care 27:682-687
13. Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN (1999) Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 22:262-270
14. Malaguarnera R, Sacco A, Voci C, Pandini G, Vigneri R, Belfiore A (2012) Proinsulin binds with high affinity the insulin receptor isoform A and predominantly activates the mitogenic pathway. Endocrinology 153:2152-2163
15. Frasca F, Pandini G, Scalia P, et al.(1999) Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19:3278-3288
16. Vella V, Pandini G, Sciacca L, et al.(2002) A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab 87:245-254
17. Belfiore A (2007) The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr Pharm Des 13:671-686
18. Mooy JM, Grootenhuis PA, de Vries H, et al.(1995) Prevalence and determinants of glucose intolerance in a Dutch Caucasian population. The Hoorn Study. Diabetes Care 18:1270-1273
19. Alssema M, Dekker JM, Nijpels G, Stehouwer CDA, Bouter LM, Heine RJ (2005) Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality. Diabetes Care 28:860-865
20. Mooy JM, Grootenhuis PA, de Vries H, et al.(1996) Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 39:298-305
21. American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1):S62-S69
22. Matthews DR, Hosker JP, Rudenski AS, et al.(1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
23. Kupka K (1978) International classification of diseases: ninth revision. WHO Chron 32:219-225
24. Haffner SM, Bowsher RR, Mykkanen L, et al.(1994) Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes 43:1490-1493